(3-Chloro-5-fluoro-4-methoxyphenyl)boronic acid, 98%, 5g

(2E)-3-(3-chlorophenyl)-1-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

5-Formylfuran-3-boronic acid, 95.0%, 10g

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 1 - MWCO 6000 to 8000, 100 mm, 15 m, 1 Piece(s)

6-bromo-3-pyridazinol, 95.0%, 100g

Methyl 5-oxo-5-phenylpentanoate, 95.0%, 250mg

5-IODO-2-(TRIFLUOROMETHYL)BENZONITRILE, 95.0%, 1g

1-(3,5-Dicarboxybenzyl)-1H-pyrazole-3,5-dicarboxylic acid, 97%, 250mg

4-Fluoro-3-methylbenzenesulfonyl chloride, 95.0%, 5g

5-{[(4-methylphenyl)thio]methyl}-2-furoic acid, 95.0%, 250mg

1-(Benzo[d]thiazol-2-yl)-N-(3-methylbenzyl)methanamine, ��97.0%, 100mg

Methyl 4-methylbenzenesulfinate, 97%, 25g

Gallic acid monohydrate, min. 98%, pa, ACS, 100 g, plastic packaging.